Skip to content
Clinical Trials – home
Research site

Dermatologiczna Praktyka Lekarska Michal Torz, DERMACEUM Centrum Badan Klinicznych

Poland ulica Zygmunta Krasinskiego 29, 50-450 Wroclaw, Poland

  • Dermatitis atopic · Neurodermatitis
  • Adult patients

About Specializations

Dermatologiczna Praktyka Lekarska Michal Torz, DERMACEUM Centrum Badan Klinicznych in Wroclaw, Poland specialises in clinical trials of conditions such as Dermatitis atopic, Neurodermatitis, and other specialisations. This site conducts important research.

Main research areas of the site

Dermatology

The medical center is at the forefront of dermatology research, focusing on innovative treatments for skin conditions. The ongoing study on ADX-914 is a testament to its commitment to advancing therapeutic options for patients with moderate to severe atopic dermatitis.

  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer

By exploring the safety and effectiveness of new treatments, the center aims to improve patient outcomes and enhance the quality of life for those affected by chronic skin conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ulica Zygmunta Krasinskiego 2950-450 WroclawPoland
Recruiting now
no trials
Conditions studied
2

More sites in WroclawPoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Neurodermatitis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ruxolitinib
  • Sponsor:Incyte Corp.

Dermatitis atopic

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Dermatitis atopic

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bempikibart
  • Sponsor:Q32 Bio Inc.

Dermatitis atopic

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Humanised Igg1 Monoclonal Antibody Against Interleukin 22 Receptor Subunit Alpha
  • Sponsor:LEO PHARMA A/S
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.